Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Conventional (Clear Cell) Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Chromophobe Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Sarcomatoid Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Collecting Duct Carcinoma of the Kidney
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Papillary Renal Cell Carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.
|
22138691 |
2011 |
Neoplasm Invasiveness
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells.
|
20388789 |
2010 |
Chloracne
|
0.300 |
Biomarker
|
disease |
CTD_human |
Microarray analysis of gene expression in peripheral blood mononuclear cells from dioxin-exposed human subjects.
|
17101203 |
2007 |
Autoimmune Diseases
|
0.210 |
Biomarker
|
group |
RGD |
This is the first report that AHNAK can be targeted by the immune system in autoimmune disease.
|
11866458 |
2002 |
Autoimmune Diseases
|
0.210 |
Biomarker
|
group |
BEFREE |
This is the first report that AHNAK can be targeted by the immune system in autoimmune disease.
|
11866458 |
2002 |
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Hair Color
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide study of hair colour in UK Biobank explains most of the SNP heritability.
|
30531825 |
2018 |
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
|
30575882 |
2018 |
Forced expiratory volume function
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets.
|
28166213 |
2017 |
Alzheimer's Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.
|
26830138 |
2016 |
Body mass index procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany.
|
19584900 |
2010 |
Finding of body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany.
|
19584900 |
2010 |
Tumor Cell Invasion
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
IMPLICATIONS: BRD4 functions as the dominant regulator of CRPC cell migration and invasion through direct transcriptional regulation of AHNAK, which together offer a novel targetable pathway to treat metastatic CRPC.<b>Visual Overview:</b> http://mcr.aacrjournals.org/content/molcanres/17/8/1627/F1.large.jpg.
|
31110158 |
2019 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
The role of AHNAK in cancer is however unclear as the protein has previously been described as a tumor suppressor, as well as being essential for tumor metastasis and invasion, while also being implicated in selected chemotherapeutic responses.
|
29309757 |
2018 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Overall, our data indicate the efficacy of FRAEM and reveal a role of TmeA during chlamydial invasion that manifests independently of effects on AHNAK.
|
28970272 |
2017 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer.
|
28494797 |
2017 |
Tumor Cell Invasion
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
Through over expression of AHNAK in both of U87 and U251, we demonstrated that overexpression of AHNAK could inhibit glioma cell proliferation and invasion, induce apoptosis, and inhibit in vivo glioma tumor growth and ki-67 expression.
|
28928883 |
2017 |
Tumor Cell Invasion
|
0.070 |
Biomarker
|
phenotype |
BEFREE |
Since AHNAK is involved in cell migration and invasion in other metastatic tumor cells, we conducted migration and invasion assays in mesothelioma cell lines.
|
24253341 |
2014 |